
According to Pfizer, the dosing of the first group of volunteers was done in Germany last week. Stage 1 of the phase I/II trial in the U.S. will enroll up to 360 healthy people in two age groups, 18-55 and 65-85. Older adults will be immunized once a safe a dose level is established. Sites include NYU and the University of Maryland. Enrollment is scheduled to begin at the University of Rochester and Cincinnati Children's Hospital soon.
WebMD
No comments:
Post a Comment